Production (Stage)
Zimmer Biomet Holdings, Inc.
ZBH
$93.79
-$1.36-1.43%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.01% | -3.85% | 2.59% | 40.84% | -58.87% |
| Total Depreciation and Amortization | -3.49% | 5.06% | 3.17% | 1.93% | -1.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 178.38% | -205.71% | -8.24% | -9.18% | 140.22% |
| Change in Net Operating Assets | -353.95% | 122.59% | 10.12% | 32.53% | -19,409.09% |
| Cash from Operations | -24.39% | 27.95% | 7.12% | 62.02% | -61.25% |
| Capital Expenditure | -0.87% | -20.65% | 27.31% | 14.00% | 3.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -221.29% | 25.11% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.88% | -43.30% | 69.01% | -8.12% | -352.84% |
| Cash from Investing | 63.60% | -87.99% | 37.29% | -26.67% | 11.68% |
| Total Debt Issued | 137.42% | 25.86% | 1,200.00% | -35.71% | -85.99% |
| Total Debt Repaid | -1.53% | -1,600.00% | -- | -- | -- |
| Issuance of Common Stock | 3,240.00% | -97.31% | 181.82% | -88.30% | 192.23% |
| Repurchase of Common Stock | -218.28% | 87.89% | -594.18% | 24.38% | 72.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.42% | 2.44% | 0.40% | 0.00% | 1.59% |
| Other Financing Activities | -577.78% | 28.00% | -21.95% | 39.26% | -170.00% |
| Cash from Financing | 339.15% | -136.11% | -10.88% | -83.43% | 80.07% |
| Foreign Exchange rate Adjustments | 138.67% | -281.00% | 403.03% | 42.11% | -177.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,070.18% | -129.28% | 449.45% | 218.86% | -118.45% |